Dr. Vallerie McLaughlin talks about the role of the prostacyclin pathway in pulmonary hypertension (PH). Dr. McLaughlin is a specialist in Cardiology and Internal Medicine at the University of Michigan Frankel Cardiovascular Center and was involved in GRIPHON, a large study of pulmonary hypertension that led to the approval of Selexipag, an oral drug for PH.
Keep updated on all the latest PH news here: http://bit.ly/20LXxHN
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?